Evidence map›Paper›PMID 38959080›Full record

ArticleJournal of the American Chemical Society2024

The Effect of the Capping Agents of Nanoparticles on Their Redox Potential.

Pavel Savchenko, Din Zelikovich, Hadassah Elgavi Sinai, Roi Baer, Daniel Mandler

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pavel SavchenkoFritz Haber Research Center for Molecular Dynamics and Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Din ZelikovichInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Hadassah Elgavi SinaiFritz Haber Research Center for Molecular Dynamics and Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Roi BaerFritz Haber Research Center for Molecular Dynamics and Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID 0000-0001-8432-1925
Daniel MandlerInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID 0000-0003-2490-1084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered metallic nanoparticles, which are found in numerous applications, are usually stabilized by organic ligands influencing their interfacial properties. We found that the ligands affect tremendously the electrochemical peak oxidation potentials of the nanoparticles. In this work, identical gold nanoparticles were ligand-exchanged and carefully analyzed to enable a precise and highly reproducible comparison. The peak potential difference between gold nanoparticles stabilized by various ligands, such as 2- and 4-mercaptobenzoic acid, can be as high as 71 mV, which is substantial in energetic terms. A detailed study supported by density functional theory (DFT) calculations aimed to determine the source of this interesting effect. The DFT simulations of the ligand adsorption modes on Au surfaces were used to calculate the redox potentials through the thermodynamic cycle method. The DFT results of the peak potential shift were in good agreement with the experimental results for a few ligands, but showed some discrepancy, which was attributed to kinetic effects. The kinetic rate constant of the oxidation of Au nanoparticles stabilized by 4-mercaptobenzoic acid was found to be twice as large as that of the Au nanoparticles stabilized by citrate, as calculated from Laviron's theory and the Tafel equation. Finally, these findings could be applied to some novel applications such as determining the distribution of nanoparticle population in a dispersion as well as monitoring the ligand exchange between nanoparticles.

Identifiers

PMID38959080
PMCPMC11328137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.